Correction: Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Assessment of Endoscopic Submucosal Dissection for Treating Duodenal Tumors ≥ 20 mm: A Systematic Review and Meta-Analysis Based on Lesion Size

  • By

  • Daisuke Minezaki

  • Yusaku Takatori

  • Motohiko Kato

  • Yasunori Sato

  • Kohei Takizawa

  • Koichi Kurahara

  • Naomi Kakushima

  • Nobutsugu Abe

  • Osamu Dohi

  • Satoru Nonaka

  • Seiichiro Fukuhara

  • Shoichi Yoshimizu

  • Shu Hoteya

  • Yasushi Yamasaki

  • Naohisa Yahagi

  • September 30, 2026

Share

Correction: Assessment of Endoscopic Submucosal Dissection for Treating Duodenal Tumors ≥ 20 mm

Overview

This correction addresses errors in the original publication regarding the enrollment period and figures related to endoscopic submucosal dissection (ESD) for duodenal tumors.

Background

Endoscopic submucosal dissection (ESD) is a minimally invasive technique used for the resection of gastrointestinal tumors, including duodenal tumors. Accurate reporting of clinical data is essential for guiding treatment decisions.

Data Highlights

No numerical data or trial results are provided in the correction.

Key Findings

  • The enrollment period for Inoue et al. (2014) was corrected from 2004–2019 to 1993–2011.
  • Figure 1 was published incorrectly and has been corrected in the original publication.
  • Supplementary files 1, 2, 3, 4, and 8 contained errors and have been replaced with correct files.
  • Endoscopic resection is preferred for superficial non-ampullary duodenal epithelial tumors without deep invasion.
  • Higher perforation rates have been reported with ESD in the duodenum compared to other sites.

Clinical Implications

Clinicians should be aware of the corrected data regarding ESD for duodenal tumors.

Conclusion

This correction serves to clarify previously reported data.

Related Resources & Content

  1. Correction: Assessment of Endoscopic Submucosal Dissection for Treating Duodenal Tumors ≥ 20 mm, Journal of Gastrointestinal Surgery, 2025 -- DOI: 10.1007/s00535-025-02335-8
  2. Journal of Gastrointestinal Surgery — Comparative Outcomes of Surgical and Endoscopic Resection for Duodenal Neuroendocrine Tumors in Terms of Disease-Specific Survival
  3. ASCO Publications — A multi-institutional analysis of duodenal neuroendocrine tumors: Tumor biology rather than extent of resection to dictate prognosis.
  4. ASCO Publications — A multi-institutional analysis of duodenal neuroendocrine tumors: Tumor biology rather than extent of resection to dictate prognosis.
  5. Endoscopic Resection of Non-Ampullary Duodenal Subepithelial Lesions: Findings from a Retrospective Cohort Analysis
  6. World Endoscopy Organization Position Statements for the Role of Endoscopy on the Diagnosis and Treatment of Superficial Non‐Ampullary Duodenal Epithelial Tumors
  7. Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size - PubMed
  8. Clinical Outcomes of Underwater Endoscopic Submucosal Dissection for Duodenal Tumors: A Systematic Review and Meta‐Analysis - Kirita - 2026 - Digestive Endoscopy - Wiley Online Library

Original Source(s)

Related Content